Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Weiss, Daniel J  [Clear All Filters]
Journal Article
Weiss DJ. Cell-based Therapy for Chronic Obstructive Pulmonary Disease. Rebuilding the Lung. Ann Am Thorac Soc. 2018;15(Supplement_4):S253-S259.
Ikonomou L, Freishtat RJ, Wagner DE, Panoskaltsis-Mortari A, Weiss DJ. The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases. Professional Societies Need to Act. Ann Am Thorac Soc. 2016;13(8):1205-1207.
Hoffman ET, Uriarte JJ, Uhl FE, Eckstrom K, Tanneberger AE, Becker C, Moulin C, Asarian L, Ikonomou L, Kotton DN, et al. Human alveolar hydrogels promote morphological and transcriptional differentiation in iPSC-derived alveolar type 2 epithelial cells. Sci Rep. 2023;13(1):12057.
Viswanathan S, Le Blanc K, Ciccocioppo R, Dagher G, Filiano AJ, Galipeau J, Krampera M, Krieger L, Lalu MM, Nolta J, et al. An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for . Cytotherapy. 2023.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, et al. International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. Cytotherapy. 2023;25(9):920-929.
Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, et al. International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2015.
Tanneberger AE, Weiss DJ, Magin CM. An Introduction to Engineering and Modeling the Lung. Adv Exp Med Biol. 2023;1413:1-13.
Abreu SCarvalho, Enes SRolandsson, Dearborn J, Goodwin M, Coffey A, Borg ZD, Santos CCDos, Wargo MJ, Cruz FFerreira, Loi R, et al. Lung Inflammatory Environments Differentially Alter Mesenchymal Stromal Cell Behavior. Am J Physiol Lung Cell Mol Physiol. 2019.
Lathrop MJ, Brooks EM, Bonenfant NR, Sokocevic D, Borg ZD, Goodwin M, Loi R, Cruz F, Dunaway CW, Steele C, et al. Mesenchymal Stromal Cells Mediate Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation by Inhibition of the Th17 Signaling Pathway. Stem Cells Transl Med. 2014.
La Francesca S, Ting AE, Sakamoto J, Rhudy J, Bonenfant NR, Borg ZD, Cruz FF, Goodwin M, Lehman NA, Taggart JM, et al. Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study. Transplant Res. 2014;3(1):19.
Wagner DE, Cardoso WV, Gilpin SE, Majka S, Ott H, Randell SH, Thébaud B, Waddell T, Weiss DJ. An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases. Ann Am Thorac Soc. 2016;13(8):S259-S278.
Weiss DJ, Chambers D, Giangreco A, Keating A, Kotton D, Lelkes PI, Wagner DE, Prockop DJ. An Official American Thoracic Society Workshop Report: Stem Cells and Cell Therapies in Lung Biology and Diseases. Ann Am Thorac Soc. 2015;12(4):S79-S97.
Crabbé A, Liu Y, Sarker SF, Bonenfant NR, Barrila J, Borg ZD, Lee JJ, Weiss DJ, Nickerson CA. Recellularization of Decellularized Lung Scaffolds Is Enhanced by Dynamic Suspension Culture. PLoS One. 2015;10(5):e0126846.
Santos CCDos, Vaswani CM, Mei SHJ, Rocco PRM, Weiss DJ, Stewart DJ, W Liles C. Reply: Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury. Eur Respir J. 2023;61(2).
Ikonomou L, Wagner DE, Turner L, Weiss DJ. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases. Ann Am Thorac Soc. 2019.